Kürpig S - Search Results

1

Uptake of PSMA-ligands in normal tissues is dependent on tumor load in patients with prostate cancer.

Gaertner FC, Halabi K, Ahmadzadehfar H, Kürpig S, Eppard E, Kotsikopoulos C, Liakos N, Bundschuh RA, Strunk H, Essler M. Gaertner FC, et al. Among authors: kurpig s. Oncotarget. 2017 Jul 6;8(33):55094-55103. doi: 10.18632/oncotarget.19049. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903405 Free PMC article.

2

Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer.

Ahmadzadehfar H, Eppard E, Kürpig S, Fimmers R, Yordanova A, Schlenkhoff CD, Gärtner F, Rogenhofer S, Essler M. Ahmadzadehfar H, et al. Among authors: kurpig s. Oncotarget. 2016 Mar 15;7(11):12477-88. doi: 10.18632/oncotarget.7245. Oncotarget. 2016. PMID: 26871285 Free PMC article.

3

Radioligand therapy of metastatic prostate cancer using ¹⁷⁷Lu-PSMA-617 after radiation exposure to ²²³Ra-dichloride.

Ahmadzadehfar H, Zimbelmann S, Yordanova A, Fimmers R, Kürpig S, Eppard E, Gaertner FC, Wei X, Hauser S, Essler M. Ahmadzadehfar H, et al. Among authors: kurpig s. Oncotarget. 2017 Feb 25;8(33):55567-55574. doi: 10.18632/oncotarget.15698. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903443 Free PMC article.

4

Early side effects and first results of radioligand therapy with (177)Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study.

Ahmadzadehfar H, Rahbar K, Kürpig S, Bögemann M, Claesener M, Eppard E, Gärtner F, Rogenhofer S, Schäfers M, Essler M. Ahmadzadehfar H, et al. Among authors: kurpig s. EJNMMI Res. 2015 Dec;5(1):114. doi: 10.1186/s13550-015-0114-2. Epub 2015 Jun 20. EJNMMI Res. 2015. PMID: 26099227 Free PMC article.

5

Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer with 177Lu-PSMA-617.

Ferdinandus J, Eppard E, Gaertner FC, Kürpig S, Fimmers R, Yordanova A, Hauser S, Feldmann G, Essler M, Ahmadzadehfar H. Ferdinandus J, et al. Among authors: kurpig s. J Nucl Med. 2017 Feb;58(2):312-319. doi: 10.2967/jnumed.116.178228. Epub 2016 Sep 1. J Nucl Med. 2017. PMID: 27587707 Free article.

6

⁶⁸Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with ²²³Ra: Proof of Concept.

Ahmadzadehfar H, Azgomi K, Hauser S, Wei X, Yordanova A, Gaertner FC, Kürpig S, Strunk H, Essler M. Ahmadzadehfar H, et al. Among authors: kurpig s. J Nucl Med. 2017 Mar;58(3):438-444. doi: 10.2967/jnumed.116.178533. Epub 2016 Sep 22. J Nucl Med. 2017. PMID: 27660148 Free article.

7

The impact of repeated cycles of radioligand therapy using [¹⁷⁷Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer.

Yordanova A, Becker A, Eppard E, Kürpig S, Fisang C, Feldmann G, Essler M, Ahmadzadehfar H. Yordanova A, et al. Among authors: kurpig s. Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1473-1479. doi: 10.1007/s00259-017-3681-9. Epub 2017 Mar 23. Eur J Nucl Med Mol Imaging. 2017. PMID: 28337529

8

Overall survival and response pattern of castration-resistant metastatic prostate cancer to multiple cycles of radioligand therapy using [¹⁷⁷Lu]Lu-PSMA-617.

Ahmadzadehfar H, Wegen S, Yordanova A, Fimmers R, Kürpig S, Eppard E, Wei X, Schlenkhoff C, Hauser S, Essler M. Ahmadzadehfar H, et al. Among authors: kurpig s. Eur J Nucl Med Mol Imaging. 2017 Aug;44(9):1448-1454. doi: 10.1007/s00259-017-3716-2. Epub 2017 May 9. Eur J Nucl Med Mol Imaging. 2017. PMID: 28488028

9

Prediction of Normal Organ Absorbed Doses for [177Lu]Lu-PSMA-617 Using [44Sc]Sc-PSMA-617 Pharmacokinetics in Patients With Metastatic Castration Resistant Prostate Carcinoma.

Khawar A, Eppard E, Sinnes JP, Roesch F, Ahmadzadehfar H, Kürpig S, Meisenheimer M, Gaertner FC, Essler M, Bundschuh RA. Khawar A, et al. Among authors: kurpig s. Clin Nucl Med. 2018 Jul;43(7):486-491. doi: 10.1097/RLU.0000000000002102. Clin Nucl Med. 2018. PMID: 29688951

10

Outcome and safety of rechallenge [¹⁷⁷Lu]Lu-PSMA-617 in patients with metastatic prostate cancer.

Yordanova A, Linden P, Hauser S, Meisenheimer M, Kürpig S, Feldmann G, Gaertner FC, Essler M, Ahmadzadehfar H. Yordanova A, et al. Among authors: kurpig s. Eur J Nucl Med Mol Imaging. 2019 May;46(5):1073-1080. doi: 10.1007/s00259-018-4222-x. Epub 2018 Nov 24. Eur J Nucl Med Mol Imaging. 2019. PMID: 30474706

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters